Skip to main content
Digital Seminar

Basic Neurobiology

Bessel A. van der Kolk, MD |  Martin Teicher, MD, PhD |  Rachel Yehuda, PhD
2 Hours 25 Minutes
May 20, 2022
Product Code:
Media Type:
Digital Seminar
Never expires.


This recording provides an overview of neurobiology and helps clinicians understand how to best treat their clients who were maltreated in childhood. Bessel A. van der Kolk, MD, covers the origins of the diagnosis of PTSD and current limitations to the diagnosis.  He discusses the importance of Developmental Trauma Disorder and neuroimaging in PTSD.

Martin Teicher, MD, PhD provides an indepth understanding of neurological consequences of childhood maltreatment and how this impacts different regions of the brain. He also explores the importance of resiliency, network architecture of the brain, and how ecophenotypes can help clinicians make better informed decisions of therapeutic approaches.

Rachel Yehuda, PhD explains the importance of psychedelic-assisted therapy for trauma, PTSD, and intergenerational trauma and how this approach can create excellent results for certain clients.



PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This program is worth 2.5 hours CPD for points calculation by your association.



Bessel A. van der Kolk, MD's Profile

Bessel A. van der Kolk, MD Related seminars and products

Trauma Research Foundation

Bessel A. van der Kolk, MD, is a clinician, researcher and teacher in the area of post-traumatic stress. His work integrates developmental, neurobiological, psychodynamic and interpersonal aspects of the impact of trauma and its treatment.

Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma. He has published over 150 peer-reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theater, and EMDR. 

He is founder of the Trauma Center in Brookline, Massachusetts and President of the Trauma Research Foundation, which promotes clinical, scientific, and educational projects. 

His 2014 #1 New York Times best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma, transforms our understanding of traumatic stress, revealing how it literally rearranges the brain’s wiring – specifically areas dedicated to pleasure, engagement, control, and trust. He shows how these areas can be reactivated through innovative treatments including neurofeedback, somatically based therapies, EMDR, psychodrama, play, yoga, and other therapies.

Dr. van der Kolk is the past president of the International Society for Traumatic Stress Studies, and professor of psychiatry at Boston University Medical School. He regularly teaches at conferences, universities, and hospitals around the world.


Speaker Disclosures:
Financial: Dr. Bessel van der Kolk is a professor at Boston University School of Medicine, the Director of the Trauma Center, and the National Complex Trauma Network. He receives royalties as a published author. Dr. van der Kolk receives a speaking honorarium, recording royalties, and book royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Bessel van der Kolk has no relevant non-financial relationships with ineligible organizations.

Martin Teicher, MD, PhD's Profile

Martin Teicher, MD, PhD Related seminars and products

Martin Teicher, MD, PhD, has been director of the Developmental Biopsychiatry Research Program at McLean Hospital since 1988. He was the director of the former Developmental Psychopharmacology Laboratory (now the Laboratory of Developmental Neuropharmacology) and is currently an associate professor of psychiatry at Harvard Medical School.

Dr. Teicher is a member of the editorial board of the Journal of Child and Adolescent Psychopharmacology, Current Pediatric Reviews, and Current Psychosomatic Medicine. He is a member of the Scientific Advisory Council of the Juvenile Bipolar Research Foundation and has been part of Harvard University’s Brain Development Working Group. He has served on or chaired numerous review committees for the National Institutes of Health, published more than 150 articles, and has received numerous honors.


Speaker Disclosures:
Financial: Dr. Martin Teicher has employment relationships with Harvard Medical School and McLean Hospital. He receives grants from ANS Research Foundation, MIDA, Harvard Brain Science Initiative Bipolar Disorder Seed Grant, NIH/NIDA - National Institute on Drug Abuse. Dr. Teicher receives compensation as a consultant. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Martin Teicher serves on the scientific advisory board for SMARTfit™ and is a board member of the National Academy of Sciences, Engineering and Medicine, the Children, Youth and Families of National Academy of Sciences, and the Trauma Research Foundation. He is a trustee of Robert E. Kahn MD and Elizabeth L. Kahn Family Foundation. Dr. Teicher is a member of the International Behavioral Neuroscience Society, the International Society for Traumatic Stress Studies, the Society of Biological Psychiatry, and the American Academy of Child and Adolescent Psychiatry. He is a is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.

Rachel Yehuda, PhD's Profile

Rachel Yehuda, PhD Related seminars and products

Rachel Yehuda, PhD, Professor of Psychiatry and Neuroscience, is the Director of the Center for Psychedelic Psychotherapy and Trauma Research. She is also Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine, which includes the PTSD clinical research program and the Neurochemistry and Neuroendocrinology laboratory the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies.

She has authored more than 450 published papers, chapters, and books in the field of traumatic stress and the neurobiology of PTSD. Her current interests include the study of risk and resilience factors, psychological and biological predictors of treatment response in PTSD, genetic and epigenetic studies of PTSD and the intergenerational transmission of trauma an PTSD. She has an active federally-funded clinical and research program that welcomes local and international students and clinicians.

Speaker Disclosures:
Financial: Dr. Rachel Yehuda has an employment relationship with the Icahn School of Medicine at Mount Sinai and the Department of Veterans Affairs. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Rachel Yehuda is a member of the International Society for Traumatic Stress Studies, the International Society for Neuroscience, and the Anxiety Disorder Association of America. She serves on the scientific advisory board for the National Anxiety Foundation. Dr. Yehuda is an ad hoc grant reviewer for the VA Merit Review Committee, the Department of Defense (DOD), and the National Institute of Mental Health (NIMH).


  1. Implement techniques to improve PTSD symptoms based on pre-trauma and post-trauma factors of enduring effects and individual differences.
  2. Choose appropriate interventions for developmental trauma associated with neurological consequences of childhood maltreatment.
  3. Apply strategies for effective treatments for maltreated individuals with psychiatric symptoms that focus on reducing the nodal efficiency of select nodes.


  • Bessel A. van der Kolk, MD
    • Origins of the diagnosis PTSD
    • ACES in the military
    • Developmental Trauma Disorder
    • Neuroimaging in PTSD
  • Martin Teicher, MD, PhD
    • Neurological consequences of childhood maltreatment
    • 5 parts of the brain in trauma
      • Amygdala, hippocampus, sensory cortex, prefrontal cortex, networks and pathways
    • Resiliency
    • Network architecture
    • Ecophenotypes
  • Rachel Yehuda, PhD
    • Psychedelic-assisted therapy for trauma, PTSD, and intergenerational trauma
    • Enduring effects and individual differences
    • PTSD remains difficult to treat with current approaches
    • Psychedelic-assisted therapy benefits
    • Brief history of psychedelics
    • Psychedelics and rapid results

Target Audience

  • Addiction Counselors
  • Counselors
  • Therapists
  • Psychotherapists
  • Marriage & Family Therapists
  • Nurses
  • Physicians
  • Psychologists
  • Social Workers
  • Other Mental Health Professionals

Please wait ...

Back to Top